SLC40A1 and breast cancer: Breast cancer cells exploit iron for increased proliferation by enhancing iron uptake through transferrin receptor overexpression, suppressing iron export via ferroportin downregulation, and utilizing iron storage proteins such as ferritin to prevent oxidative damage.